Senior insider sale
RECURSION PHARMACEUTICALS, INC. — senior position signals high conviction
$897.2K
260K shares
What this filing means
BORGESON BLAKE plans to sell 260K shares of RECURSION PHARMACEUTICALS, INC. valued at approximately $897.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/2/2026ACC: 0001959173-26-004239
Director
Since Apr 2021
260K
Shares to sell
$897.2K
Approx. market value
30K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Founders Shares
Compensation
9/19/2017
30KTotal acquired30K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/19/2017 | Founders Shares Compensation | 30K | — |
| Total | 30K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
30K
Market value
$105.6K
5/5/2026
—Completed
Units to sell
30K
Market value
$93.0K
4/7/2026
—Completed
Units to sell
170K
Market value
$588.2K
3/3/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
30K
Market value
$110.4K
6/2/2026
Total
Units
260K
Value
$897.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/5/2026 | 30K | $105.6K | — | Completed |
4/7/2026 | 30K | $93.0K | — | Completed |
3/3/2026 | 170K | $588.2K | — | Completed |
| Planned — Approximate Date | ||||
6/2/2026 | 30K | $110.4K | NASDAQ | Planned |
| Total | 260K | $897.2K | ||